The Medtechy Daily: October 10
The Medtechy Daily provides the latest news and insight for the medical technology industry, including medical device, biotech and digital health.
Are you a recruiter or company looking to fill positions in the medical sales industry, including biotech, pharmaceuticals and medical device? We are offering free job postings through the end of 2018 with the discount code 'MEDTECHY'. Learn more in this post or create a free account and company homepage here.
Tweets of the Day
When @MiMedx ordered people to “bleach” their Hard Drives, information found its way to Thumb Drives.. Imagine that and who has the Thumb Drives ? $MDXG @AIMhonesty @AureliusValue @viceroyresearch . There is Stupid and then there is Stupid. @WSJ @business @JohnEdwardsAJC— Marc Cohodes (@AlderLaneeggs) October 9, 2018
Allergan works toward blockbuster goal with new jawline approval for CoolSculpting. The FDA greenlighted the body contouring treatment to combat fat below the jawline, making it the first nonsurgical fat reduction system with a go-ahead to contour that area. Regulators based their decision on a 22-week clinical study that showed an average 33% reduction in fat layer thickness after two treatments, Allergan said. (FiercePharma)
Who Should I Turn to for Vascular Surgery? Although vascular surgeons are, as the name implies, well versed in surgical techniques, Dr. William P. Shutze, a vascular surgeon at Baylor Scott and White The Heart Hospital – Plano in Texas, says that often the care patients receive is not surgical in nature. (U.S. News & World Report)
Why Peter Thiel is backing a tiny start-up waging war against the global superbug crisis.It's not surprising that Breakout Labs, the Thiel Foundation's seed-stage fund that aims to propel radical science to improve human health, has invested in SciBac, a company targeting the growing problem of antibiotic resistance. (CNBC)
CVS and Aetna are gaining ground after their $69 billion merger gets the green light (CVS, AET). Stocks were down sharply on Wednesday, but CVS and Aetna provided a rare bright spot. Both stocks were higher after the companies received regulatory approval for their $69 billion merger. CVS was up 0.9% and Aetna was higher by 1.3%. (Business Insider)
Seventh Surgeon Pleads Guilty In Forest Park Medical Center Bribery Scam. 53-year-old Wade Neal Barker, one of Forest Park’s founding doctors, appeared in court this morning, where he pleaded guilty to conspiracy to pay and receive healthcare bribes and kickbacks as well as aiding and abetting commercial bribery. (Medtechy)
Researchers Test New Techniques to Rule Out and Predict Heart Attacks. A new protocol to rule out myocardial infarctions (MIs), or heart attacks, in emergency departments using a recently approved high-sensitivity troponin t test was found to be safe and accurate in a study published in Circulation. (JAMA)
AdvaMed Backs Wright Medical in Hip Liability Case. The Utah Supreme Court will decide whether to apply to medical devices a key legal doctrine that protects manufacturers of technologically-advanced products from the unfair application of strict liability. (MDDI)